Raymond Liu

Summary

Publications

  1. ncbi N-acetylcysteine for the prevention of contrast-induced nephropathy. A systematic review and meta-analysis
    Raymond Liu
    Department of Medicine, University of California, San Francisco, CA, USA
    J Gen Intern Med 20:193-200. 2005
  2. ncbi Tumor regrowth between surgery and initiation of adjuvant therapy in patients with newly diagnosed glioblastoma
    Andrea Pirzkall
    Department of Radiology and Margaret Hart Surbeck Laboratory of Advanced Imaging, University of California, San Francisco, San Francisco, CA, USA
    Neuro Oncol 11:842-52. 2009

Collaborators

  • Joachim Ix
  • Andrea Pirzkall
  • Sarah J Nelson
  • Colleen McGue
  • Scott Vandenberg
  • Susan M Chang
  • Mitchel S Berger
  • Suja Saraswathy
  • Soonmee Cha
  • Kathleen R Lamborn

Detail Information

Publications2

  1. ncbi N-acetylcysteine for the prevention of contrast-induced nephropathy. A systematic review and meta-analysis
    Raymond Liu
    Department of Medicine, University of California, San Francisco, CA, USA
    J Gen Intern Med 20:193-200. 2005
    ..We conducted a systematic review to determine whether administering N-acetylcysteine around the time of contrast administration reduces the risk of contrast-induced nephropathy...
  2. ncbi Tumor regrowth between surgery and initiation of adjuvant therapy in patients with newly diagnosed glioblastoma
    Andrea Pirzkall
    Department of Radiology and Margaret Hart Surbeck Laboratory of Advanced Imaging, University of California, San Francisco, San Francisco, CA, USA
    Neuro Oncol 11:842-52. 2009
    ..The acquisition of metabolic and physiologic imaging data prior to adjuvant therapy may also be valuable in assessing regions of new CE and nonenhancing tumor...